SCHEMBL16405337

SCHEMBL16405337

Cc1cc(Cl)cc(Cl)c1C(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAPGEF4 Q8WZA2 1/20 0.42
GABRA1 P14867 1/20 0.39
GABRB1 P18505 1/20 0.39
ALDH1A1 P00352 3/20 0.39
LMNA P02545 2/20 0.39
SCN4A P35499 2/20 0.37
AHR P35869 2/20 0.37
TSHR P16473 4/20 0.36
HSD17B10 Q99714 3/20 0.36
CYP3A4 P08684 1/20 0.36
RECQL P46063 1/20 0.36
HTT P42858 2/20 0.35
TP53 P04637 1/20 0.35
BCL2 P10415 1/20 0.34
BCL2L1 Q07817 1/20 0.34
MCL1 Q07820 1/20 0.34
BCL2L2 Q92843 1/20 0.34
ALB P02768 2/20 0.33
LDHA P00338 1/20 0.33
LDHB P07195 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10073283 0.90 GABRA1 (0.42) RAPGEF4GABRA1GABRB1LMNASCN4A
SCHEMBL11985992 0.84 ALDH1A1 (0.47) RAPGEF4GABRA1GABRB1ALDH1A1LMNA
SCHEMBL18886070 0.81 GABRA1 (0.52) RAPGEF4GABRA1GABRB1LMNASCN4A
SCHEMBL12237882 0.80 LMNA (0.39) RAPGEF4ALDH1A1LMNATSHRHTT
SCHEMBL19121891 0.79 GABRA1 (0.35) RAPGEF4GABRA1GABRB1LMNASCN4A
SCHEMBL19304128 0.79 GABRA1 (0.45) GABRA1GABRB1ALDH1A1LMNASCN4A
SCHEMBL24663933 0.76 CYP3A4 (0.52) GABRA1GABRB1ALDH1A1LMNAHSD17B10
SCHEMBL19869248 0.76 MAP3K14 (0.41) GABRA1GABRB1ALDH1A1SCN4ATSHR
SCHEMBL19126691 0.75 GABRA1 (0.39) RAPGEF4GABRA1GABRB1ALDH1A1LMNA
SCHEMBL13220712 0.75 GABRA1 (0.56) GABRA1GABRB1ALDH1A1LMNAAHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9795953-B2 Organometallic catalysts BERGEN TEKNOLOGIOVERFORING AS (NO) 2017-10-24 US disclosed
US-20160214098-A1 NOVEL ORGANOMETALLIC CATALYSTS BERGEN TEKNOLOGIOVERFORING AS (NO) 2016-07-28 US disclosed
US-9303100-B2 Organometallic catalysts BERGEN TEKNOLOGIOVERFORING AS (NO) 2016-04-05 US disclosed
US-20150025212-A1 NOVEL ORGANOMETALLIC CATALYSTS BERGEN TEKNOLOGIOVERFORING AS (NO) 2015-01-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160214098-A1 NOVEL ORGANOMETALLIC CATALYSTS ZKSCAN2, ZC3HAV1L, ZRANB2 RAPGEF4 1279/4885GABRA1 2667/4885GABRB1 3166/4885
US-20150025212-A1 NOVEL ORGANOMETALLIC CATALYSTS ZKSCAN2, ZC3HAV1L, ZRANB2 RAPGEF4 1279/4885GABRA1 2667/4885GABRB1 3166/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.